Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.52%

Enanta Pharmaceuticals, Inc. (ENTA)

-NMS
40.44 Down 0.04(0.10%) Jul 10, 3:59PM EDT
Prev Close:40.48
Open:39.62
Bid:34.30 x 200
Ask:42.00 x 100
1y Target Est:43.50
Beta:0.543
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:39.20 - 40.94
52wk Range:16.85 - 46.44
Volume:131,989
Avg Vol (3m):210,889
Market Cap:749.64M
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENTA

Comparison

Symbol% ChgMkt Cap
ENTADown 0.10%749.64M
IDIXDown 0.41%3.62B
MRKUp 0.05%171.19B
VRTXDown 0.29%23.10B

Key Statistics

Forward P/E (1 yr):4.27
P/S (ttm):124.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :0.69
Quarterly EPS Est (Jun-14) :1.67
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enanta Pharmaceuticals, Inc., a biotechnology company, is engaged in the development of small molecule drugs for the infectious disease field. Its product portfolio includes ABT-450, a protease inhibitor that is in Phase III clinical trials for th... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback